Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

UBM Announces Content for 10th Annual Japanese Pharma & Bio Events


News provided by

UBM Live

08 Mar, 2011, 23:08 GMT

Share this article

Share toX

Share this article

Share toX

AMSTERDAM, March 8, 2011 /PRNewswire/ --

Leading events organiser UBM Live (http://www.ubmlive.com) and its sister company, UBM Japan Co. Ltd. (http://www.ubmjapan.com/corp/en/index.html), today announced details of the anticipated content and new developments taking place at the tenth anniversary of CPhI Japan, a leading International pharmaceutical event, being held from 18-20 April, 2011 at the Big Sight Exhibition Center in Tokyo. The full line-up of events surrounding CPhI Japan includes P-MEC Japan, which covers Pharma machinery and equipment, ICSE Japan, which looks at outsourcing solutions, and BioPh Japan, which showcases the biopharma sector. Attendance to the shows is free through pre-registration at http://www.cphijapan.com.

One significant development this year is that, based on the positive feedback received for the 2010 BioPh Pavilion, BioPh is to be introduced as a stand-alone event focusing on the increasing convergence of pharma and biotech business models in global healthcare. It will feature exhibitors in areas such as bioinformatics, diagnostics, genomics and proteomics, and process validation. CPhI Japan's other co-located shows, ICSE and P-MEC, have also shown healthy growth in popularity and size since their introductions in 2005 and 2008 respectively, and expect to continue this upwards trend in 2011.

"The response from exhibitors and attendees to the BioPh Pavilion was excellent and the interest generated last year has proven strong enough to expand into a dedicated event," commented Haf Cennydd, Event Director of ICSE/P-MEC/BioPh Japan. "It's also very pleasing to see that both ICSE Japan and P-MEC Japan have flourished and built a reputation as being key meeting places for pharma expertise. We are expecting strong turnouts for the events once again in 2011. Much of this growth can be attributed to the developments in the Japanese generic drug market. Manufacturers in this industry are currently keen to establish stable sources for APIs, and companies that can provide such sources with the right quality and appropriate price points will be at the events to promote their products and services. The rich networking platform and 'matchmaking' opportunities that our Japanese shows provide are reflected in the positive growth in their popularity. It's a win-win situation for all parties."

In celebration of CPhI Japan's ten year anniversary, an extensive seminar program featuring more than 120 sessions to be held over the three-day period. Attendees from each show will have the option to attend one of the many sessions where speakers will cover the most current and relevant topics in the industry. Topics include: significant developments for the pharmaceutical industry in Japan in 2010; pricing system reform for innovative drugs; improvements in drug approvals; and, the importance of the pharmaceutical industry as a driver of economic growth. Special seminars organized by the Japan Pharmaceutical Manufacturers Association (JPMA) will present issues such as quality assurance in the supply chain and the developments of biologics. More details of the seminars content can be found at http://www.cphijapan.com.

After a successful introduction in 2010, a special workshop, "A Practical Guideline to the Revised Pharmaceutical Affairs Law," will once again be hosted for International guests. Participants of the workshop will have the chance to ask questions about the pharmaceuticals affairs laws directly to the officials taking part in the workshop. Questions will be invited on, amongst other subjects, the maintenance of Master File Systems for drug substances, the accreditation processing of foreign manufacturers, the application for GMP Compliance, inspection procedures for foreign manufacturers.

"CPhI Japan's appeal is global, and the Japanese pharma market's steady track record of growth and progress has contributed to CPhI Japan's global appeal. It has become known as a global meeting place where attendees can find major suppliers of quality pharmaceutical ingredients under one roof," commented Annemieke Timmers, CPhI Brand Director at UBM Live. "Specifically, Japan is the second largest pharma market after the US and accounted for approximately 11% of the world market in 2010, around $US60 billion in revenue and Japan's generic drug sector is expected to triple by 2012(1). IMS Health forecasts that the Japanese pharmaceutical market will increase to $US79 billion within five years and nearly double to $US105 billion by 2023(1)."

UBM Live's combined CPhI Japan 2010 events saw over 450 exhibitors from 29 countries despite the air travel disruptions caused by the Icelandic volcanic eruption. Even with the travel setbacks, CPhI Japan grew 5.2% between 2009 and 2010; it was attended by over 14,000 visitors. Further reflecting the truly global nature of the events, CPhI Japan will host national pavilions for Italy, China, Korea, the UK ,Spain and India, JBPMA, while formal supporters of the event include Japan's Ministry of Health, Labour and Welfare, the Ministry of Economy, Trade and Industry ,trade associations and industry organisations.

Further information is available (including an offer for free attendance through pre-registration) at http://www.cphijapan.com. Further information about the co-located events can be found online at: http://www.icsejapan.com, http://www.bioph-japan and http://www.pmec-japan.com. For more information on other global events, please visit us online at: http://www.cphi-sa.com, http://www.cphi-india.com, http://www.cphi-china.com or http://www.cphi.com.

(1) Sources:

http://www.leaddiscovery.co.uk/reports/236/Japanese_Pharmaceutical_Market_20062011/ http://www.bioportfolio.com/cgi-bin/acatalog/The_Japanese_Pharmaceutical_Market_2008-2023.html https://www.espicom.com/Prodcat.nsf/Search/00000352?OpenDocument http://www.echinachem.com/EN/News/0907/2009771128393431.shtml http://www.ims-japan.co.jp/industry_trends_top_line_information.php

Notes for Editors:

- With offices in the UK, Netherlands, USA, UAE and Brazil, UBM Live operates a number of market leading exhibitions, awards, websites/online products and publications in twenty different business sectors. UBM Live is part of UBM Ltd, a leading global media company listed on the London Stock Exchange. See http://www.ubmlive.com

- UBM Ltd is a leading global business media company. We inform markets and bring the world's buyers and sellers together at events, online, in print and provide them with the information they need to do business successfully. Our 6,000 staff in more than 30 countries are organised into specialist teams that serve these communities, helping them to do business and their markets to work effectively and efficiently. See http://www.ubm.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.